Generative AI in Pharma Regulation: Insights from FDA, EMA, and Health Canada
Reading Time: 4 mins The U.S. Food and Drug Administration’s (FDA) stance on GenAI is clear: it’s a groundbreaking advancement with huge potential, particularly in healthcare. However, ensuring accuracy and safety remains paramount amidst concerns about transparency and misuse. […]
Generative AI in Pharma Regulation: Insights from FDA, EMA, and Health Canada Read More »